4th International Conference on Ophthalmology and Eye Disorder

London, UK

November 1-2, 2018

Eric SOUIED earned his MD and Ph.D. degrees in 1990-2006, at the University Paris Est (UPE) Professor Eric H Souied has contributed to more than 380 peer-reviewed publications in the areas of age-related macular degeneration (AMD), hereditary retinal diseases, ophthalmic genetics and multimodal imaging. He began in the field on genetics in 1993 with Pr Arnold Munich, working on the genetics of retinitis pigmentosa and Stargardt disease. In 1995, he had a precursor vision on the pathogenesis of AMD and decided to investigate a novel hypothesis: the role of genetics in AMD. Eric explored emerging therapies and protocols for AMD, DME, RVO, including anti-VEGF treatments. He has led or participated in several studies engaged in exploring new therapeutics. He is the founder president of the French “Association DMLA” and the founder president of the French society “Federation France Macula”. Pr Eric Souied has been nominated in the Power List of the top100 most influent people in the world of ophthalmology by the journal « the ophthalmologist ».

Born in 1950 in the region of Transylvania, Romania. He Graduated from the Hebrew University – Hadassah Medical School in Jerusalem, Israel in 1974. In 1985 he finished his residency in Ophthalmology, and in 1990 a fellowship in Neuro-Ophthalmology at the University of Michigan in Ann-Arbor, MI, USA. For the last twenty-five years is the head of the Neuro-Ophthalmology service at the Hadassah Medical Center in Jerusalem, Israel. In addition to his longstanding clinical work, he has collaborated internationally with several medical services in research studies, wrote few chapters in medical textbooks, co-authored almost forty articles published in the international medical literature, lectured in many Ophthalmological & Neuro-Ophthalmological conferences and organized tens of courses along the years in Neuro-Ophthalmology in various meetings.

Professor Ambrósio is a world-class refractive surgeon, who is considered a true clinician-scientist. With more than 500 publications and more than 60 awards in Brazil and abroad, he was voted the 11th most influential ophthalmologist by the British journal, The Ophthalmologist in 2014, and again was included among the top 100 in 2016 and 2018. In 2007, he founded The Rio de Janeiro Corneal Tomography and Biomechanics Study Group, from which over one hundred publications were originated.

Dr. Khalifa received his Ph.D. ( Tanta University, Tanta, Egypt) thesis in the evaluation of emmetropia after cataract extraction and IOL implantation in 1985. He was the first one to stress on the importance of white to white diameter in the anticipation of PO IOL position ( a formula called TNT formula). He had his fellowship in Cataract IOL from University of Tennessee Center for Health Sciences in 1985, TN, USA. His research is focused on correction of the refractive condition of the eye either by corneal refractive surgery or lenticular refractive surgery through premium IOL’s. He published many papers in the field of customized LASIK with meticulous evaluation of HOA’s. He received the international achievement award from AAO in 2016 for his work in the past 20 years. He is a reviewer for many international journals for several years. Also, he is a President of Egyptian Refractive Club (ERC).

Mubarak F. Al. Faran is currently a Dean, College of Medicine & Supervisor, University Hospitals, King Saud University. He is also Chairman of Medical Committee in King Saud University. He is a Professor of Ophthalmology, College of Medicine, King Saud University and an Editorial Board Member of Saudi Journal of Ophthalmology. Professor Mubarak Al Faran has a membership of Saudi Ophthalmological Society and American Academy of Ophthalmology.

Professor Mohammad Pakravan has won an Achievement Award from American Academy of Ophthalmology. He is a Member of Iranian Ophthalmology Association and also a member of European Society of Cataract and Refractive Surgeons. He has published more than 62 peer-reviewed articles and also a book and two chapters of two books. From 2006 till present he holds the position of Educational Director of Ophthalmology Section, at Labbafinejad Medical Center.

Professor Gábor Holló is Director of the Glaucoma Service and Perimetry Unit in the Department of Ophthalmology at Semmelweis University. Dr Holló is the recipient of several awards, including the Széchenyi Professor Award (2000), the European Glaucoma Society’s (EGS) Special Recognition Award (2003), the Schulek Vimos Award by the Hungarian Ophthalmology Society (2014), and the Anagnostakis - Trantas Gold Medal by the Greek Glaucoma Society. He is a former Executive Committee member of the EGS, and the Founder and for 15 years the President of the Glaucoma Section of the Hungarian Ophthalmology Society. His work for the EGS notably includes a contribution to the development of the European Diagnostic and Treatment Guidelines.